K063567 · Vidacare Corporation · FMI · Jan 26, 2007 · General Hospital
Device Facts
Record ID
K063567
Device Name
EZ-MIO STERNAL
Applicant
Vidacare Corporation
Product Code
FMI · General Hospital
Decision Date
Jan 26, 2007
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 880.5570
Device Class
Class 2
Attributes
Therapeutic
Intended Use
Sternal IO access is indicated for adult patients when rapid fluid or pharmacological resuscitation is required in emergencies
Device Story
EZ-MIO Sternal is a single-use manual intraosseous infusion system. It consists of a needle set (stylet and catheter) with a permanently attached driver and depth-control collar. The device is used by clinicians in emergency settings to manually insert the needle through the sternal cortex into the bone marrow. After insertion, the stylet is removed by turning the hub counter-clockwise, leaving the Luer-lock catheter seated in the bone. The catheter allows connection to standard syringes or IV tubing for fluid and drug administration. The device facilitates rapid vascular access when peripheral IV access is difficult or impossible, potentially improving patient outcomes during resuscitation.
Clinical Evidence
No clinical data provided; substantial equivalence is based on technological characteristics and design similarities to legally marketed predicate devices.
Technological Characteristics
Manual intraosseous infusion system; 15G x 25mm needle set (stylet and catheter); single-use driver; depth-control collar; Luer lock interface for fluid/drug administration; sterile; biocompatible materials.
Indications for Use
Indicated for adult patients requiring rapid fluid or pharmacological resuscitation in emergency settings.
Regulatory Classification
Identification
A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set.
{0}------------------------------------------------
Premarket Notification [510(k)], Vidacare, EZ-Mi
## 5. 510(k) Summary
JAN 2 6 2007
Image /page/0/Picture/3 description: The image shows the word "vidacare" in a stylized, sans-serif font. The letters are bold and black, with a slightly futuristic or technical appearance. The font has rounded corners and a uniform stroke width, giving it a clean and modern look.
722 Isom Road, San Antonio, TX 78216 Tel (210) 375 8500 Fax (210) 375 8537 Toll Free (within US) 866 479 8500 www.vidacare.com
### SUMMARY
Submitter's name: Address:
Vidacare Corporation 722 Isom Road San Antonio, TX 78216 210-375-8500 210-375-8537
Phone: Fax number:
Name of contact person:
Grace Holland Regulatory Specialists, Inc 3722 Ave. Sausalito Irvine, CA 92606 Phone: 949-262-0411 Fax: 949-552-2821
Date the summary was prepared: November 3, 2006
Name of the device: Trade or proprietary name: Common or usual name: Classification name:
EZ-MIO Sternal EZ-MIO Sternal Intraosseous Infusion System Hypodermic single lumen needle
The legally marketed devices to which we are claiming equivalence [807.92(a)(3)]:
| 510(k)<br>Number | Trade or Proprietary or<br>Model Name | Manufacturer |
|------------------|------------------------------------------------------|--------------------|
| K052195 | EZ-MIO Manual Driver | Vidacare Corp. |
| K970380 | F.A.S.T. 1 Intraosseous<br>Infusion System (powered) | PYNG Medical Corp. |
{1}------------------------------------------------
# Description of the device:
The EZ-MIO Sternal is very similar to the EZ-MIO, manual driver, previously cleared under 510(k) K052195. The two minor differences between the devices are in the driver and addition of a collar to the needle set. The predicate EZ-MIO consists of a proprietary pentagon shaft permanently attached to an ergonomically designed reusable driver. The EZ-MIO Sternal is single use and has a smaller driver permanently attached to the needle set. The second difference is the EZ-MIO Sternal has a permanently attached collar added to the same needle set used by the EZ-MIO. The collar is used to control depth of penetration. Both products utilize the same needle set and are designed to allow the user to manually insert a needle set consisting of a stylet and catheter through the cortex of a bone to a desired depth within the bone marrow to facilitate the infusion of desired fluids. After insertion of the needle set, both systems function identically by allowing the user to remove a stylet from the catheter by turning the stylet hub counter clockwise leaving a standard Luer lock catheter securely seated in the bone. The catheter Luer lock permits attachment of standard syringes and IV tubing for administration of drugs and fluids (not supplied). The needle set size used in the sternum is the identical needle set used by the predicate EZ-MIO (15G X 25mm). The EZ-MIO system is approved for use in the proximal tibia under 510(k) K052195. This submission requests an indication for use of the EZ-MIO Sternal in the sternum location already established by the predicate device Pyng F.A.S.T.1 (K970380).
Indications:
Sternal IO access is indicated for adult patients when rapid fluid or pharmacological resuscitation is required in emergencies
Summary of the technological characteristics of our device compared to the predicate devices:
The EZ-MIO Sternal has the exact same technology as the EZ-MIO cleared under 510(k) K052195. There have been no major changes to the design or components and therefore the comparison of technological characteristics such as target
{2}------------------------------------------------
population, needle design, technique, sterility, biocompatibility and where it is used is identical.
Vidacare also wishes to use as a predicate F.A.S.T. 1 Intraosseous Infusion System, K970380, by PYNG Medical Corp., as this system has been cleared for use in the sternal location for which we are applying.
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features a stylized caduceus, a symbol often associated with medicine and healthcare, with three abstract human profiles facing right. The words "DEPARTMENT OF HEALTH AND HUMAN SERVICES . USA" are arranged in a circular pattern around the caduceus.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Vidacare Corporation C/O Ms. Grace Holland Regulatory Specialist Regulatory Specialist, Incorporated 3722 Avenue Sausalito Irvine, California 92606
JAN 2 6 2007
Re: K063567
Trade/Device Name: EZ-MIO Sternal Regulation Number: 880.5570 Regulation Name: Hypodermic Single Lumen Needle Regulatory Class: II Product Code: FMI Dated: November 24, 2006 Received: November 28, 2006
Dear Ms. Holland:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{4}------------------------------------------------
#### Page 2 - Ms. Holland
Please be advised that FDA's issuance of a substantial equivalence determination does not Please be advised that FDA Sissamed on that your device complies with other requirements meall mat ITDA nas made a deceminations administered by other Federal agencies. of the Act of ally rederal statutes and reguirements, including, but not limited to: registration You must comply with an the Het Free Progations (21 CFR Part 801); good manufacturing practice and ifsing (21 CFR Part 807), labolity systems (QS) regulation (21 CFR Part 820); and if requirents as set form in the quality broken (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) This icter will anow you to begin mainent of substantial equivalence of your device to a premarket notification. - The PDF Inish is a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), If you desire spocitio actrice to: Joine at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the may outmit our. Echerariational and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Chiu Lin, Ph.D.
Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
## 4. Indications for Use Statement Indications for Use
510(k) Number (if known):
Device Name: EZ-MIO Sternal
Sternal IO access is indicated for adult patients when rapid fluid or pharmacological resuscitation is required in emergencies
Prescription Use
(Part 21 CFR 801 Subpart D) X
AND/OR Over-The-Counter Use _ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Am 0. m
Anesthesiology, Chinanol Murq. Tal. nrol, Dental Devices
REGULATORY SPECIALISTS, INC.
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.